Genomics and Epitranscriptomics Regulation in Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 688
Special Issue Editors
Interests: cancer genomics; bioinformatics; algorithms; machine learning; genomic instability
Special Issue Information
Dear Colleagues,
Cancer pathogenesis involves not only genetic alterations but also sophisticated layers of post-transcriptional regulation that collectively dictate malignant phenotypes. The emergence of epitranscriptomics, the study of post-transcriptional RNA modifications, has unveiled a dynamic regulatory dimension in cancer biology, complementing established genomic and transcriptomic perspectives.
This Special Issue aims to compile advanced research and reviews that elucidate the roles of genomic and epitranscriptomic mechanisms in cancer development, progression, and treatment. Research areas may include (but are not limited to) the following:
- Mutations, copy number variations, and structural variations in cancer genomes;
- The role of RNA modifications in tumorigenesis, metastasis, and therapy response;
- Regulatory roles of microRNAs, long non‑coding RNAs, and circular RNAs in cancer;
- Genetic and epitranscriptomic alterations contributing to resistance against therapeutic strategies;
- Epitranscriptomic regulators as therapeutic targets.
We look forward to receiving your contributions.
Dr. Ilias Georgakopoulos-Soares
Dr. Candace S. Y. Chan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer genomics
- epitranscriptomics
- RNA modifications
- non-coding RNAs
- gene expression regulation
- RNA splicing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
